Determination of gabapentin-lactam in serum of patients under gabapentin therapy

Arzneimittel-Forschung/Drug Research

Volumn 54, Issue 3, 2004, Pages 139-142

  Knörle, Rainer ^a   Feuerstein, Thomas J ^b   Schulze Bonhage, Andreas ^b,c  

^a IBAM Inst F Biochemische A   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Neurozentrum   (Germany)

Author keywords

CAS 601 42 96 3; Epilepsy; Gabapentin; Gabapentin lactam, determination in serum, neuroprotection, patients; Neurontin

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; GABAPENTIN; GABAPENTIN LACTAM; LACTAM; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DRUG DETERMINATION; DRUG EFFECT; ENZYME ACTIVITY; EPILEPSY; FEMALE; FOCAL EPILEPSY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; NERVE DEGENERATION; NEUROPROTECTION; NEUROTRANSMITTER RELEASE;

EID: 1642302663     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296950     Document Type: Article

References (12)

1. Ng, G. Y., Bertrand, S., Sullivan, R. et al., Gamma-aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action. Mol. Pharmacol. 59, 144 (2001)
2. B receptor agonist. Neuropharmacology 41, 965 (2001)
3. Bruni, J. on behalf of the NEON Study investigator group, Outcome evaluation of gabapentin as add-on therapy for partial seizures. Can. J. Neurol. Sci. 25, 134 (1998)
4. Chadwick, D. W., Anhut, H., Greiner, M. J. et al., A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures, International Gabapentin Monotherapy Study Group. Neurology 51, 1282 (1998)
5. Gurney, M. E., Cutting, F. B., Zhai, P. et al., Benefit of vitamin E, riluzole and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol. 39, 147 (1996)
6. Miller, R. G., Moore, D. H. II, Gelinas, D. F. et al., Western ALS Study Group Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology 56, 843 (2001)
7. Kearney, A. S., Mehta, S. C., Radebaugh, G. W., The effect of cyclodextrins on the rate of intramolecular lactamization of gabapentin in aqueous solution. Int. J. Pharm. 78, 25 (1991)
8. 3H]-glutamate release and is a neuroprotective agent of acute retinal ischemia. Naunyn-Schmiedeberg's Arch. Pharmacol. 362, 74 (2000)
9. Lagrèze, W., Müller-Velten, R., Feuerstein, T. J., The neuroprotective properties of gabapentin-lactam. Graefe's Arch. Clin. Exp. Ophthalmol. 239, 845 (2001)
10. Feuerstein, T. J., Zucker, B., Neuroprotection. Neuropediatrics 33, A8 (2002)
11. Ratnaraj, N., Patsalos, P. N., A high-performance liquid chromatography micromethod for the simultaneous determination of vigabatrin and gabapentin in serum. Ther. Drug Monit. 20, 430 (2001)
12. Ross, R. W., Lau-Cam, C. A., General reversed-phase high-performance liquid chromatographic method for the separation of drugs using triethylamine as a competing base. J. Chromatogr. 370, 403 (1986)